ATM and breast cancer: We also performed a sensitivity analysis that excluded from the “High” Group the genes that were significantly (or borderline) associated with BC in our population (i.e., ATM, CHEK2, PALB2, FANCM, MAST1) to test whether the differential effect was driven by those genes.